(Q46225142)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Expression of receptors for luteinizing hormone-releasing hormone (LH-RH) in prostate cancers following therapy with LH-RH agonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Stephen V Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

4

Shigang Xiong

1 reference

8 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

author name string

Debra Hawes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Laden Fazli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Martin Gleave

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jie Cai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Susan Groshen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Frank Brands

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Juergen Engel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jacek Pinski

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

English

0 references

publication date

29 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

4675-4680

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium

8 February 2020

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Gonadotropin-releasing hormone (GnRH) and GnRH receptor in bladder cancer epithelia and GnRH effect on bladder cancer cell proliferation.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Gonadotropin-releasing hormone specific binding sites in normal and malignant renal tissue

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Inhibition of growth of experimental prostate cancer in rats by LH-RH analogs linked to cytotoxic radicals

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Luteinizing hormone-releasing hormone receptor-targeted chemotherapy using AN-152

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Chemotherapy targeted to cancers through tumoral hormone receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Immunohistochemical demonstration of gonadotropin-releasing hormone receptors in prostate carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-10-1113

Identifiers

DOI

10.1158/1078-0432.CCR-10-1113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670943%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference